Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni ™ mass spectrometer to enable disease researchers to move beyond canonical protein ...
The First Precision Oncology Trial to Use a Functional Proteomics and Phosphoproteomics Assay for Treatment Decision Making in a Pan-Tumor Study Golden, CO, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Ignite ...
The limitations imposed by evolution have implications for AI tools trained on existing sequences and de novo protein design ...
The number of known proteins is infinitely small in comparison to the universe of possible proteins, which could in theory be ...
The high-protein food and drink trend is booming. Once the domain of bodybuilders and gym-goers, protein-packed products have now hit the mainstream. The movement shows no signs of slowing. Today, ...
Similarly, the now enabled timsOmni deep proteoform methods are equally powerful in interrogating drug targets, as well as biologics, including therapeutic antibodies, ADCs, multispecifics, and their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results